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The ubiquitin ligase Hul5 was recently identified
as a component of the proteasome, a multi-
subunit protease that degrades ubiquitin-pro-
tein conjugates. We report here a proteasome-
dependent conjugating activity of Hul5 that
endows proteasomes with the capacity to ex-
tend ubiquitin chains. hul5 mutants show re-
duced degradation of multiple proteasome
substrates in vivo, suggesting that the polyubi-
quitin signal that targets substrates to the pro-
teasome can be productively amplified at the
proteasome. However, the products of Hul5
conjugation are subject to disassembly by a
proteasome-bound deubiquitinating enzyme,
Ubp6. A hul5 null mutation suppresses a ubp6
null mutation, suggesting that a balance of
chain-extending and chain-trimming activities
is required for proper proteasome function.
As the association of Hul5 with proteasomes
was found to be strongly stabilized by Ubp6,
these enzymes may be situated in proximity
to one another. We propose that through dy-
namic remodeling of ubiquitin chains, protea-
somes actively regulate substrate commitment
to degradation.
INTRODUCTION
The ubiquitin-proteasome system mediates the break-
down of most short-lived regulatory proteins, and in this
way it controls many aspects of cell physiology. A central
element of this system, the proteasome, is also its mostCell 1complex, with over 30 distinct integral subunits (Pickart
and Cohen, 2004). The proteasome degrades substrates
within its core particle (CP or 20S particle), which is a bar-
rel-shaped assembly of 670 kDa whose hollow interior
houses multiple proteolytic sites. Protein substrates reach
this interior chamber through a gated channel, guided by
the regulatory particle (RP, 19S, or PA700), which is a com-
plex of 1 MDa. The RP recognizes the substrate-bound
ubiquitin chain, unfolds the substrate, and directs its
translocation into the CP. The need for an unfolding step
owes to the narrow cross-section of the channel leading
to the CP (Pickart and Cohen, 2004). Critical components
of the RP include ubiquitin receptors, deubiquitinating
enzymes, and six ATPases that have been implicated in
substrate unfolding and translocation.
Recent work has shown that factors associated with the
proteasome via loose, often salt-labile interactions play
important roles in regulating its function (Schmidt et al.,
2005). UBL-UBA proteins, for example, help to deliver
specific ubiquitin conjugates to the proteasome (Verma
et al., 2004; Elsasser et al., 2004; Madura, 2004). Among
the most abundant proteasome-associated proteins of
S. cerevisiae are two enzymatic factors: Ubp6, a deubiqui-
tinating enzyme, and Hul5, a ubiquitin-protein ligase (Leg-
gett et al., 2002). Ubp6 is one of two deubiquitinating en-
zymes within the proteasome; in contrast, a much larger
number of ubiquitin ligases (nine) have been suggested
to interact with the proteasome, including Ubr1, Ufd4,
the APC, and the SCF (Xie and Varshavsky, 2000, 2002;
Verma et al., 2000; You and Pickart, 2001; Leggett et al.,
2002; Seeger et al., 2003; reviewed in Schmidt et al.,
2005). However, Hul5 is the only ligase observed on pro-
teasomes in amounts high enough to be visible by con-
ventional protein staining (Leggett et al., 2002). Hul5 is
evolutionarily conserved, and its likely mammalian ortho-
log, KIAA10, also associates with proteasomes (You and
Pickart, 2001; Wang and Pickart, 2005).27, 1401–1413, December 29, 2006 ª2006 Elsevier Inc. 1401
Figure 1. Stabilization of Short-Lived Proteins in hul5D Mutants
(A) Cycloheximide chase analysis of Gcn4 in wild-type (WT) and hul5D cells (left panel). The degradation defect was complemented by Hul5
expressed from its own promoter on a CEN plasmid but not by the active-site mutant Hul5-C878A (right). hul5D also stabilized TAP-tagged Met4
(Figure S1). Values represent the average of three independent experiments. Error bars show standard deviation from the mean.
(B) As in (A), but the substrate was a2, and turnover was assessed in rpn4D and rpn4D hul5D mutants. Values represent the average of three
independent experiments. Error bars show standard deviation from the mean.1402 Cell 127, 1401–1413, December 29, 2006 ª2006 Elsevier Inc.
In this study we report genetic and biochemical charac-
terization of Hul5. hul5 null mutants are deficient in protein
degradation, but, unlike typical ubiquitin ligase mutants,
they do not show highly substrate-specific defects in deg-
radation. Rather, the hul5 phenotype more closely resem-
bles that of a partial proteasome loss-of-function mutant.
In vitro, Hul5 endows proteasomes with a potent ubiquitin-
ligase activity, which can extend unanchored multiubiqui-
tin chains or ubiquitin chains bound to a proteolytic sub-
strate such as cyclin B. Ubiquitin chain extension by
Hul5 is strongly stimulated by proteasomes, suggesting
that proteasomes are a principal site of ubiquitination by
Hul5. Ubiquitin groups added to proteasome-bound tar-
get proteins by Hul5 can be efficiently removed by
Ubp6. These and other observations imply that Hul5
and Ubp6 function in opposition with one another. We
suggest that by maintaining and extending ubiquitin
chains on proteasome-bound substrates, Hul5 stabilizes
proteasome-substrate interactions and promotes protein
breakdown.
RESULTS
hul5 Mutants Exhibit Reduced Proteolytic Capacity
To test for a role of Hul5 in proteasome function, we exam-
ined the effects of deleting the HUL5 gene on the rates of
turnover of several short-lived proteins. Substantial stabi-
lization of the transcriptional activator Gcn4 was observed
in hul5Dmutants (Figure 1A). This effect could be comple-
mented by a HUL5 gene carried on a low copy-number
CEN plasmid. The HECT-domain ligases, of which Hul5
is a member, form covalent thiolester adducts with ubiqui-
tin as a required step in conjugation. When the adduct-
forming cysteine 878 of Hul5 was substituted with alanine,
complementation was no longer observed in the Gcn4
degradation assay (Figure 1A).
In contrast to Gcn4, the transcriptional repressor a2
was not noticeably stabilized in the hul5D mutant (data
not shown). However, defects in protein degradation can
be compensated for by upregulation of proteasome levels
(London et al., 2004; Ju et al., 2004). Rpn4 is a transcription
factor that is degraded by the proteasome and that acti-
vates transcription of proteasome subunit genes (Xie
and Varshavsky, 2001; Leggett et al., 2002; Ju et al.,
2004). rpn4D mutants show reduced proteasome levels
and an inability to upregulate proteasome subunit synthe-
sis when the ubiquitin-proteasome system is challenged.
In strains lacking Rpn4, we found that turnover of a2
was significantly affected by deletion of HUL5 (Figure 1B).
It is possible that for a2, ubiquitin conjugation is normally
rate limiting for degradation; bydeletingRPN4,proteasome
function is attenuated and becomes partially rate limiting,Cell 1so that underlying defects in proteasome function become
more apparent.
Targets of the N-end rule pathway are well-studied
model substrates of the proteasome (Varshavsky, 1996).
The Trp1 protein was converted into an N-end rule sub-
strate by fusing it to ubiquitin, with a lysine placed adja-
cent to the ubiquitin C terminus to allow recognition by
the ubiquitin ligase Ubr1 (Hanna et al., 2006). A strain bear-
ing this construct grew slowly in the absence of exoge-
nous tryptophan but was Trp+ when UBR1 was deleted
(Figure 1C). Hul5 appeared to promote degradation of
the Ub-K-Trp1 fusion protein, because deletion of the
HUL5 gene conferred a growth advantage to this strain
in the absence of tryptophan (Figure 1C). As seen with
Gcn4, this function of Hul5 required its active site cysteine
(Figure 1C). Cycloheximide chase analysis confirmed that
Ub-K-Trp1 and a comparable reporter, Ub-K-Ura3, were
stabilized by deletion of HUL5 (Figure 1D). In summary,
the stabilization of a range of substrates in hul5Dmutants
implies that Hul5 serves a general function at the protea-
some. The defects in protein degradation in hul5D mu-
tants appear to be more general than expected for a ubiq-
uitin-protein ligase since ubiquitin ligases tend to be highly
substrate specific.
Hul5-Dependent Ubiquitination on the Proteasome
The results above, taken together with our earlier finding
that Hul5 associates with proteasomes (Leggett et al.,
2002), suggested that Hul5 may stimulate the breakdown
of multiple proteins by promoting their ubiquitination at
the proteasome. To test whether Hul5 can mediate ubiqui-
tination of proteasome-bound proteins, we incubated
affinity-purified proteasomes with biotinylated ubiquitin,
ubiquitin-activating enzyme (E1), and ATP. Proteasomes
converted free ubiquitin into conjugates with surprising ef-
ficiency (Figure 2A). When purified from hul5D mutants,
however, proteasomes were virtually devoid of this activ-
ity. Thus, although previous studies have indicated that
other ligases can bind proteasomes with some affinity,
this simple assay for ligase activity is specific for Hul5. Fur-
thermore, the role of Hul5 in the proteasome’s ubiquitin li-
gase activity is direct since proteasomes bearing a catalyt-
ically inactive form of Hul5, Hul5-C878A, were comparable
to those of hul5D in their conjugation deficiency (Fig-
ure 2A). The selective detection of Hul5 activity may reflect
that it is present on proteasomes at higher levels than
other ligases in our preparations (Leggett et al., 2002). In
addition, we suggest that the assay preferentially detects
Hul5 because it is unique among proteasome-associated
ligases in the nature or breadth of its substrate specificity.
Proteasomes are associated with deubiquitinating ac-
tivity as well as ubiquitin ligase activity. An integral subunit(C) Effect of deleting HUL5 on growth of a strain expressing a Ub-K-Trp1 fusion protein. Plates were incubated for 3 (+Trp) or 7 (Trp) days. As in (A),
the degradation defect was complemented by plasmid-borne HUL5 but not by hul5-C878A.
(D) As in (A), but the test substrates were Ub-K-Trp1 and Ub-K-Ura3. These two bands were quantitated together. All chase experiments were initiated
by the addition of cycloheximide to 100 mg/ml, except in (A) where 20 mg/ml was used. Values represent the average of three independent experi-
ments. Error bars show standard deviation from the mean.27, 1401–1413, December 29, 2006 ª2006 Elsevier Inc. 1403
Figure 2. Hul5-Dependent Ubiquitin-Ligase Activity of Purified Proteasomes
(A) Proteasomes from WT and mutant strains were incubated for 1 hr with biotinylated ubiquitin, E1, and ATP. UbBIOT indicates biotinylated ubiquitin,
Ubconj indicates ubiquitin-protein conjugates, and * indicates self-ubiquitinated E1 (data not shown). Samples were analyzed by SDS-PAGE. After
blotting, ubiquitin conjugates were visualized with HRP-Streptavidin. Left and central panels show different exposures of the same blot.
(B) Ubiquitin-protein conjugation assays were performed with proteasomes purified from ubp6D and hul5D ubp6D strains as in (A). The leftmost panel
shows a time course of the conjugation reaction. The 120 min sample was ATP depleted, then incubated with or without stoichiometric amounts of
recombinant Ubp6. Time points were taken, and the samples were analyzed as in (A).of the proteasome, Rpn11, removes ubiquitin chains en
bloc from conjugates, apparently cutting at the sub-
strate-proximal end of the chain (Verma et al., 2002; Yao
and Cohen, 2002). A second proteasomal deubiquitinat-
ing enzyme is Ubp6, a proteasome-associated protein
(Verma et al., 2000; Leggett et al., 2002) that progressively
trims chains (Hanna et al., 2006). While cleavage by Rpn11
is coupled to substrate degradation (Verma et al., 2002;
Yao and Cohen, 2002), the activity of Ubp6 is not; on the
contrary Ubp6 can inhibit degradation (Hanna et al., 2006).
When the conjugate-synthesis assay was carried out
using ubp6D proteasomes, both the yield of conjugates
and their average molecular weight increased significantly
(Figure 2A), suggesting that conjugates synthesized by
Hul5 can be substrates of Ubp6. To test this possibility,
we prepared conjugates using ubp6D proteasomes,
then quenched further conjugate synthesis by depleting
ATP. Upon addition of purified Ubp6, we observed nearly
complete elimination of high molecular weight conjugates
by 30 min, while in the absence of Ubp6 these conjugates
persisted for at least 90 min (Figure 2B, right panel). Thus,
conjugates formed by Hul5 on the proteasome are favor-
able substrates for Ubp6.
For the model substrates shown above to be stabilized
in a hul5D mutant (Figure 1), E3 requirements have previ-
ously been defined, so it is unlikely that Hul5 could serve
as a major E3 for these proteins (Meimoun et al., 2000;
Swanson et al., 2001; Varshavsky, 1996). If not an E3,
Hul5 could function as a member of a rarer and more re-
cently recognized group of ubiquitin ligases known as
E4 enzymes, which are defined as specialized mediators
of ubiquitin chain elongation (Koegl et al., 1999; Richly
et al., 2005). Thus, an E4 enzyme should not modify a pro-
tein unless it has been previously ubiquitinated through
the action of an E3. To test whether Hul5 can elongate pre-
formed ubiquitin chains, we purified Hul5 (Figure S2) and
assayed its ubiquitin-ligase activity using tetraubiquitin
chains (Ub4) as substrate. These chains were efficiently1404 Cell 127, 1401–1413, December 29, 2006 ª2006 Elsevierelongated in a reaction mixture that included E1, E2,
Hul5, and proteasomes, but not when Hul5 was omitted
(Figure 3A). Also required for this reaction was the protea-
some holoenzyme. These data suggest that Hul5 can
serve as an E4, and that its enzymatic activity is stimulated
by proteasomes, just as for Ubp6 (Leggett et al., 2002).
The E4 model assumes that tetraubiquitin is being used
as a ubiquitin acceptor rather than a donor in these conju-
gation reactions. This assumption was confirmed through
biochemical analysis of the product conjugates. Tetraubi-
quitin carries a free C-terminal carboxylate group and
therefore can, like ubiquitin, be activated by E1 and sub-
sequently be donated to substrates. The ‘‘tetraubiquitin
donor’’ model, an alternative to the E4 model, predicts
that the conjugates produced by Hul5 lack a ubiquitin-
derived C-terminal carboxylate; that is, they are conven-
tional ubiquitin-protein conjugates rather than free chains.
However, isopeptidase T, which is specific for free ubiqui-
tin chains, digested the Hul5 reaction products readily
(Figure 3B). Thus, tetraubiquitin plays an acceptor role in
these conjugation reactions, consistent with the E4 model
in which Hul5 extends chains. The predominant donor in
these reactions appears to be free ubiquitin, which is sup-
plied in excess (Figure S3).
Proteins are thought to be targeted to the proteasome
principally by Lys48-linked ubiquitin chains (Pickart and
Cohen, 2004). However, when tested with single-lysine
ubiquitin derivatives, Hul5 formed chains more efficiently
on Lys63 than on Lys48 (Figure 3C). To confirm the linkage
preference of Hul5, we used mass spectrometry to map
the linkage site on chains formed with wild-type (WT) ubiq-
uitin. This analysis revealed a strong preference for the for-
mation of Lys63 linkages (Figure 3D). Thus, Hul5 has the
capacity to build chains with heterogeneous ubiquitin-
ubiquitin linkages. Hul5 can build off Lys48-linked chains,
but in vitro it produces mainly Lys63 linkages. Whether this
apparent chain specificity represents a functionally signif-
icant parameter for Hul5 in vivo remains to be assessed.Inc.
The ability of Hul5 to promote protein degradation in vivo
suggests that Hul5 should be able to extend ubiquitin
chains on defined degradative substrates. We tested this
using cyclin B, a highly unstable protein. Cyclin B was ex-
pressed in insect cells, complexed to Cdc2, purified, and
ubiquitinated by the APC ligase (Kirkpatrick et al., 2006).
The resulting conjugates are degraded almost to comple-
tion within 5 min by ubp6D proteasomes (Hanna et al.,
2006). Ubp6, when added to such proteasomes, progres-
sively trims the ubiquitin chains of cyclin B. Since the APC
modifies cyclin B extensively, the conjugates do not run
far into the gel, making it difficult to detect further chain ex-
tension. We therefore used Ubp6 to reduce the extent of
cyclin B ubiquitination (Figure 3E, compare lanes 2 and 7)
while suppressing cyclin B degradation with the protea-
some inhibitor PS341 and blocking Rpn11-mediated deu-
biquitinating activity with o-phenanthroline. After 20 min of
Ubp6-dependent processing, Hul5 was added, resulting in
efficient addition of ubiquitin groups to the cyclin B conju-
gate (Figure 3E). Importantly, Hul5 was inactive on cyclin
B that had not been ubiquitinated by the APC (Figure 3E,
lane 6), indicating that Hul5 does not function as an E3
for cyclin B, but rather as an E4.
Although Figure 3E shows that Hul5 acts preferentially
on previously ubiquitinated cyclin B, it does not show
that Hul5 elongates pre-existing ubiquitin chains on cyclin
B. Alternatively, Hul5 might conjugate ubiquitin to lysine
residues of cyclin B. According to the E4 model, the ubiq-
uitin chains on cyclin B should both target the conjugate
to Hul5 and provide the acceptor lysine residues for fur-
ther ubiquitination. The latter possibility was tested by
preparing ubiquitin cyclin B conjugates with mutant ubiq-
uitin lacking Lys48 and Lys63, the two lysines that Hul5
preferentially utilizes for chain extension. Unlike Hul5,
the APC can utilize Lys11 in addition to Lys48 and
Lys63, and Lys48 is not required for in vitro degradation
of ubiquitinated cyclin B by ubp6D proteasomes (Kirkpa-
trick et al., 2006). Conjugates lacking Lys48- and Lys63-
linked ubiquitin chains were also degraded by purified
yeast proteasomes (ubp6D) with an efficiency close to
that of conjugates synthesized with WT ubiquitin (data
not shown). However, when Hul5 was challenged with
such conjugates in the presence of WT free ubiquitin
as a donor, it failed to catalyze significant ubiquitination
(Figure 3F). These results imply that Hul5 elongates pre-
formed ubiquitin chains on cyclin B, as expected of an
E4 enzyme.
Hul5 Extends Ubiquitin Chains on Rpn10
To examine how Hul5 might promote proteasome function
in vivo, we searched for endogenous ubiquitin conjugates
that were hypoubiquitinated in the hul5Dmutant. Ubiquitin
was expressed in a 6-histidine-tagged form, and total cel-
lular conjugates were isolated by Ni-NTA-affinity chroma-
tography under nondenaturing conditions and in the pres-
ence of proteasome inhibitor. The eluates were subjected
to mass spectrometry and to immunoblot analysis with an-
tibodies to various proteins in experiments to be reportedCell 1more fully elsewhere. Most notably, proteasome subunit
Rpn10 was observed via this enrichment procedure to
be extensively modified by ubiquitination (Figure 4A).
Rpn10 was seen to be modified in both the WT and
hul5D samples, but species bearing more than four ubiqui-
tin groups were much reduced in hul5D samples (Fig-
ure 4A). Thus, Hul5 may act as an E4 for Rpn10 in vivo.
The observation of Rpn10 ubiquitination led us to examine
its turnover. Surprisingly, Rpn10 is an unstable protein
and undergoes Hul5-dependent degradation (Figure 4B).
Thus, ubiquitin chain extension by Hul5 appears to pro-
mote degradation of this novel proteasome substrate.
We next assayed Hul5 E4 activity on oligo-ubiquitinated
Rpn10. We performed conjugation assays with WT and
hul5D proteasomes in the presence of a chromatographic
fraction (fraction 8; see Supplemental Data) that was ac-
tive in forming oligo-ubiquitinated Rpn10. Fraction 8, pre-
pared from a hul5D strain, catalyzed oligo-ubiquitination
of Rpn10 by means of a yet uncharacterized E3. When
this reaction was supplemented with hul5D proteasomes,
Rpn10 conjugates did not exceed four ubiquitin moieties
(Figure 4C, lane 5), as found for endogenous Rpn10 con-
jugates recovered from hul5D cells (Figure 4A, right lane).
In contrast, incubations with WT proteasomes produced
strong polyubiquitination of Rpn10 (Figure 4C, lane 10).
Proteasome inhibitor PS341 dramatically increased the
accumulation of high-molecular-weight conjugates (Fig-
ure 4C, compare lanes 9 and 10), suggesting that this
pool of conjugates includes degradative intermediates of
Rpn10. Thus, formation of long conjugates by Hul5 is ap-
parently linked to Rpn10 proteolysis in vitro, as observed
in vivo in Figures 4A and 4B.
Affinity-purified proteasomes are associated with ubiq-
uitin conjugates, probably substoichiometrically (Chen
and Madura, 2002; Elsasser et al., 2004). The presence
of these conjugates could reflect their capture by the pro-
teasome as well as conjugate synthesis at the protea-
some. Suggestive of the latter possibility, proteasome-as-
sociated conjugates were severely reduced in abundance
in hul5D mutants, and their apparent molecular weights
were likewise strongly reduced (Figure 5A). Analysis of
proteasome-associated species by two-dimensional
IEF/SDS-PAGE (Figure 5A, right panels) and by mass
spectrometry (data not shown) indicated that they were
heterogeneous. While reduced in hul5D mutants, the en-
dogenous proteasome-associated conjugates were ele-
vated in ubp6Dmutants (Figure 5B), presumably reflecting
that they are substrates of Ubp6 in WT cells. Accordingly,
recombinant Ubp6 converted the ubiquitin immunoreac-
tive material in these conjugates into low-molecular-
weight species (Figure 5C, lane 5). When the catalytic
site of Ubp6 was inactivated by C118A substitution, the
conjugates were not processed (Figure 5C, lane 7), indi-
cating that processing is mediated by the deubiquitinating
activity of Ubp6. Since Ubp6 is activated by the protea-
some (Leggett et al., 2002; Hanna et al., 2006), processing
likely occurs on the proteasome. In support of this idea,
the Ubl domain of Ubp6, which mediates complex27, 1401–1413, December 29, 2006 ª2006 Elsevier Inc. 1405
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formation with the proteasome, was also required for this
reaction (Figure 5C, lane 6).
Interestingly, in cells lacking Hul5, deletion of UBP6 did
not enhance the levels of proteasome-associated ubiqui-
tin conjugates (Figure 5B), suggesting that the disassem-
bly of conjugates synthesized by Hul5 is an important role
of Ubp6. We suggest that Hul5 mediates the formation of
these proteasome-bound conjugates and that addition of
Ubp6 to the isolated complex disassembles the endoge-
nous conjugates as seen with conjugates synthesized by
Hul5 in vitro (Figure 2B). Moreover, the endogenous con-
jugates observed in Figure 5 may serve as the ubiquitin ac-
ceptors in the in vitro experiments of Figure 2A. If true, this
would imply that Hul5 serves to enhance the recovery on
proteasomes of ubiquitin conjugates that it can further
ubiquitinate in vitro and that in this assay the products of
Hul5 conjugation are themselves the major substrates of
Hul5.
Hul5 and Ubp6 Function in Opposition
The analyses of endogenous and in vitro synthesized
ubiquitin conjugates in Figures 2–5 suggest that ubiquitin
chains bound to the proteasome exist in a dynamic state,
with both elongation and attrition of chains occurring. The
principal mediators of these reactions appear to be Hul5
and Ubp6. These observations led us to test for functional
opposition between these enzymes in vivo. Figure 6A
shows that deletion of HUL5 results in substantial sup-
pression of the previously reported (Amerik et al., 2000;
Leggett et al., 2002) canavanine sensitivity of ubp6D mu-
tants. This suggests that the phenotypic defect in ubp6D
mutants is partly attributable to the presence of Hul5, in
that Hul5 activity is unopposed by Ubp6 in the mutant. An-
other ubiquitin ligase known to bind proteasomes, the E3
enzyme Ufd4 (Xie and Varshavsky, 2000, 2002), was inac-
tive in this suppression assay (Figure 6A). It is currently un-
clear whether the suppressive effect of HUL5 deletion isCell 12mediated through increased ubiquitin levels or some other
mechanism.
Deletion of the gene encoding Ubc4, an E2 enzyme,
was found to suppress ubp6D to approximately the
same extent as HUL5, possibly because Ubc4 collabo-
rates with Hul5 in ubiquitin conjugation (Figure 6A). Null
mutations in genes encoding six other E2 enzymes failed
to suppress, indicating that the assay is specific (Fig-
ure 6A). Ubc4 is involved in the degradation of short-lived
proteins (Seufert and Jentsch, 1990), and significantly it is,
like Hul5, found in association with the proteasome (Ton-
gaonkar et al., 2000; Chuang and Madura, 2005). More-
over, our in vitro ubiquitin conjugation assays show that
Hul5 and Ubc4 productively interact (Figure 3A). There-
fore, Ubc4 is a good candidate for the physiological part-
ner of Hul5. The ability of hul5D and ubc4D mutations to
enhance growth of ubp6D mutants in the presence of
canavanine is striking, because both hul5D and ubc4D
mutants exhibit canavanine sensitivity in other contexts
(Seufert and Jentsch, 1990; data not shown).
The specific relationship between Hul5 and Ubp6 was
also apparent from compositional analysis of protea-
somes isolated from the corresponding null mutants. Un-
der relatively stringent conditions of proteasome prepara-
tion, the recovery of Hul5 on ubp6D proteasomes was
significantly reduced (Figure 6B). However, it was unclear
how hul5D could suppress ubp6D if Hul5 were not bound
to proteasomes in vivo in the ubp6Dmutant. We therefore
isolated proteasomes again from ubp6D mutants, but in
the absence of salt. These proteasomes were immobilized
on beads, and the column was step-eluted with NaCl in
25 mM increments. Hul5 dissociated from WT protea-
some primarily at 175–200 mM NaCl but from the ubp6D
proteasome at 50–75 mM (Figure 6C). Substitution of the
active site cysteine of Ubp6 had little or no effect on the
salt dependence of the Hul5-proteasome association (Fig-
ure 6C). Thus, the presence of Ubp6, whether in an activeFigure 3. Ubiquitin Chain-Extending Activity of Hul5
(A) Hul5 can extend unanchored multiubiquitin chains in a proteasome-dependent reaction. Ubiquitin-conjugation assays were performed in reac-
tions supplied with ubiquitin, E1, E2 (UbcH5), Hul5, proteasome holoenzyme (holo), and tetraubiquitin (Ub4) as shown. Reaction products were an-
alyzed by SDS-PAGE and antiubiquitin immunoblotting. Proteasomes were derived from a hul5D ubp6D strain and had been previously incubated
with Ubp6 to reduce antiubiquitin immunoreactive material (see Supplemental Data). The two asterisked bands just above Ub4 are minor contami-
nants present in the input Ub4, presumably Ub5 and Ub6 (data not shown).
(B) Tetraubiquitin (1 mg), tetra-Ub (1 mg) extended by Hul5 as in (A), and APC-generated cyclin B conjugates were incubated with isopeptidase T (0.1
mg) for 40 min at 30C. Cyclin B-ubiquitin conjugates, a negative control, are not expected to be digested with isopeptidase T.
(C) As in (A), but the added free ubiquitin contained in each case only a single lysine residue, as indicated, to support chain formation.
(D) Full MS scan spectra corresponding to either the K48 and K63 -GG signature peptides as measured in high-molecular-mass gel regions from
complete reactions with or without addition of Hul5 (lanes 3–4 from [A]). The m/z range shown includes both the digested native peptide as well
as its corresponding isotopically labeled internal standard peptide. The spectra shown represent an average of all MS spectra collected during
peak elution.
(E) E4 activity of Hul5 on cyclin B conjugates. Cyclin B conjugates were formed by the APC in 1 hr incubations (lanes 1 and 2). Conjugation assays
performed with Hul5 and proteasomes but without prior APC treatment did not show detectable ubiquitination (lanes 3–6). Cyclin B conjugates were
partially trimmed by adding purified Ubp6 then incubating for 20 min. Ubp6 was then inhibited by adding ubiquitin-aldehyde. Hul5-dependent ubiq-
uitination was observed on cyclin B conjugates partially trimmed by Ubp6 (lanes 7–10). Proteasomes were incubated with 10 mM PS341 and 10 mM
o-phenanthroline prior to reactions, and conjugation reactions were supplied with E1 and Ubc4. Mock reactions were supplemented with BSA instead
of Hul5. Here and in (F), conjugates were visualized with antibody to cyclin B (Kirkpatrick et al., 2006).
(F) Cyclin B (lanes 1 and 2) and cyclin B conjugates generated by the APC using either ubiquitin carrying K48R and K63R mutations (lanes 3 and 4) or
WT ubiquitin (lanes 5 and 6) were washed and subsequently incubated with proteasomes, Hul5, and WT ubiquitin as in (E). Different exposures of the
same gel are shown.7, 1401–1413, December 29, 2006 ª2006 Elsevier Inc. 1407
or an inactive form, stabilizes the association of Hul5 with
proteasomes. A possible consequence of this would be
that Hul5 partitions predominantly onto Ubp6-containing
proteasomes in vivo. However, Ubp6 is not essential for
recognition of Hul5 by proteasomes. Therefore, to better
understand the association of Hul5 with proteasomes,
we attempted to identify the primary Hul5 receptor.
We first examined subassemblies of the proteasome,
which are stable and can be purified in large amounts.
These consisted of the 28-subunit CP, the 19-subunit
Figure 4. Hul5 Promotes Rpn10 Ubiquitination and Turnover
(A) Ubiquitination of endogenous Rpn10. Purification of whole-cell
6HIS-ubiquitin-protein conjugates under nondenaturing conditions,
from SJR125 (WT) and SBC9 (hul5D) strains (see Supplemental Data-
for details). Conjugates were eluted with imidazole and analyzed by
SDS-PAGE and anti-Rpn10 immunoblotting.
(B) Cycloheximide chase analysis of Rpn10 in WT and hul5D cells.
Rpn5 was used as a loading control. Values represent the average of
three independent experiments. Error bars show standard deviation
from the mean.
(C) In vitro analysis of Hul5-dependent Rpn10 ubiquitination. WT and
hul5D proteasomes were incubated with ATP, 6HIS-ubiquitin, PS-
341, and hul5D extract (fraction 8) containing Rpn10 oligo-ubiquitinat-
ing activity. The lower panel shows a longer exposure.1408 Cell 127, 1401–1413, December 29, 2006 ª2006 ElsevierRP, and the two complexes that make up the RP: the
nine-subunit base, which is proximal to the CP, and the
nine-subunit lid, which is distal to the CP (Glickman
et al., 1998; Schmidt et al., 2005). Hul5 was recognized
by the RP and its constituent, the base, but it was not rec-
ognized by the CP or the lid (Figure 7A). We also tested
eight proteasome subunits individually for Hul5 binding,
and among these Rpn2 and Rpn10 were positive
(Figure 7B). However, Rpn2 bound Hul5 in an approxi-
mately stoichiometric complex, while Rpn10 captured
Hul5 inefficiently, according to Coomassie blue staining
intensities (Figure 7C). Rpn10 may not be a physiologically
significant mediator of Hul5 binding because protea-
somes isolated from rpn10D strains have WT levels of
Hul5 (Figure 7D), whereas the assignment of Rpn2 as
the physiological Hul5-binding subunit is supported by
Hul50s binding to the base, which contains Rpn2. In sum-
mary, these data suggest that Rpn2 is the principal pro-
teasomal receptor for Hul5. Rpn2 and the related
Figure 5. Antagonistic Effects of Hul5 and Ubp6 on the
Recovery of Endogenous Conjugates with Affinity-Purified
Proteasomes
(A) Proteasomes (2 mg) from WT and hul5D strains were analyzed by
SDS-PAGE (left panel) or by two-dimensional isoelectric focusing/
SDS-PAGE followed by antiubiquitin immunoblotting (center and right
panels). Rpt1 was used as a loading control. Ubconj indicates ubiq-
uitin-protein conjugates.
(B) Proteasomes from WT and mutant strains were analyzed by SDS-
PAGE and antiubiquitin immunoblotting.
(C) WT or ubp6D proteasomes (12 nM) were incubated with ATP (1
mM) and a 4-fold molar excess of the indicated recombinant Ubp6
construct. Reactions were stopped by the addition of 53 SDS-loading
buffer and analyzed by SDS-PAGE and immunoblotting. Note that
a second deubiquitinating enzyme, Rpn11, appears to be largely inac-
tive against the ubiquitin immunoreactive material.Inc.
proteasome subunit Rpn1, which is apparently the major
proteasomal binding site for Ubp6 (Leggett et al., 2002;
Stone et al., 2004), may together provide a scaffold that
brings Hul5 and Ubp6 into proximity.
DISCUSSION
A diverse set of reversibly bound proteins participates in
and regulates the function of the proteasome. Affinity pu-
rification, mass spectrometry, and other methods have
allowed for the identification of hundreds of proteasome-
associated proteins (see for example Verma et al., 2000;
Cagney et al., 2001; Leggett et al., 2002; Guerrero et al.,
2006). These proteins remain poorly characterized on
the whole and probably represent a mixture of protea-
some cofactors, ubiquitin-protein conjugates, and non-
Figure 6. Genetic andBiochemical Interactions betweenHul5
and Ubp6
(A) Cells were spotted onto selective plates with or without 0.8 mg/ml
canavanine sulfate and grown at 30C for 3 days (above). ubc (E2)
and ufd4 (E3) mutants were also screened for suppression of
ubp6D-associated canavanine sensitivity.
(B) Proteasomes from WT and mutant strains were extensively washed
(500 bed vol.) prior to elution. Equal protein amounts were analyzed by
SDS-PAGE and immunoblotting.
(C) Proteasomes from WT, ubp6D, and ubp6C118A mutants were
bound to resin and washed with a NaCl gradient. Washes were col-
lected and analyzed by SDS-PAGE and immunoblotting.Cell 1specifically associated proteins. However, only a few pro-
teins are associated with proteasomes in high amounts
(Verma et al., 2000; Leggett et al., 2002), and each of these
tested so far modulates proteasome function and asso-
ciates with proteasomes in both yeast and mammals
(reviewed by Schmidt et al., 2005).
Among the abundant proteasome-associated proteins
is a ubiquitin ligase, Hul5. The ligase activity of Hul5 has
thus far not shown discriminatory capacity for the accep-
tor protein of the ubiquitin conjugate that it takes as a sub-
strate. Hul5 is active on bulk protein associated with the
proteasome, on synthetic tetraubiquitin chains, on ubiqui-
tin-Rpn10 conjugates, and on ubiquitin-cyclin B conju-
gates. The relaxed in vitro specificity of Hul5 parallels its
effects on protein turnover in vivo, where it was seen to
stabilize a variety of substrates. Since all substrates exam-
ined are ubiquitinated by known E3 enzymes, it is difficult
to envisage Hul5 functioning as an E3 for these degrada-
tive events. In contrast to E3 enzymes, E4 enzymes are
specialized in the elongation of ubiquitin chains and may
characteristically lack the capacity to recognize specific
determinants in the target protein (Koegl et al., 1999;
Richly et al., 2005). Instead, our data and those of Richly
et al. (2005) suggest that their specificity of action may
be determined principally by the E4’s association with
a particular protein complex. The E4-like activity of Hul5
is indicated not only by its specificity for ubiquitinated
forms of cyclin B but also by its ability to elongate tetrau-
biquitin chains. These engineered chains are not attached
Figure 7. Proteasome Subunit Rpn2 Binds Hul5
(A) Immobilized RP, CP, base (B), and lid (L) were prepared as de-
scribed (Leggett et al., 2002). A control sample (C) was from a con-
genic, untagged strain. Hul5 was bound to resin, and, after washing,
protein remaining bound to the column was analyzed by SDS-PAGE
and Hul5 immunoblotting. The leftmost lane represents 5% of input
Hul5.
(B) GST fusions of proteasome subunits and a GST control (C) were
bound to glutathione Sepharose and tested for Hul5 binding. Numeri-
cal lane designations indicate the identity of the Rpn subunit tested:
Rpn1, Rpn2, Rpn10, and so forth. Beads were treated as in (A). Equal
amounts of beads were analyzed by SDS-PAGE and immunoblotting.
(C) GST-Rpn2 and GST-Rpn10 beads were loaded with Hul5. Proteins
were then eluted with glutathione and visualized by Coomassie stain-
ing after SDS-PAGE.
(D) Equal amounts of ProA-TEV-Rpt1-tagged proteasomes, affinity-
purified from WT and rpn10D mutants, were analyzed by SDS-PAGE
and immunoblotting.27, 1401–1413, December 29, 2006 ª2006 Elsevier Inc. 1409
to a target protein, so an E3 mode of conjugate recognition
is not possible in this case.
A Hul5 substrate of particular interest is Rpn10, a pro-
teasomal ubiquitin receptor. Rpn10 is the first proteasome
subunit to be identified as a proteasome substrate and as
a major target of ubiquitination, although it should be
noted that a nonproteasomal pool of Rpn10 exists (van
Nocker et al., 1996). Hul5 appears to function as an E4
for Rpn10 because its presence is not required for the
generation of mono- or diubiquitinated forms of Rpn10
but is required to form extensively modified species of
Rpn10 in vivo and in vitro. Many ubiquitin receptors are
ubiquitinated (Kumar et al., 1999; Shih et al., 2003; Di Fiore
et al., 2003; Hoeller et al., 2006), and these modifications
are thought to be regulatory in nature. Conjugated ubiqui-
tin often blocks receptor function, apparently by occupy-
ing the ubiquitin-binding site of the receptor. In contrast,
chain extension by Hul5 appears to be critical for efficient
Rpn10 degradation in vivo and in vitro. An interesting
question is why ubiquitination targets Rpn10 for degrada-
tion, given that Rpn10 can associate with the proteasome
in the absence of this modification.
We have thus far not found Hul5 to fully stabilize any
substrate in vivo under standard growth conditions. These
observations seem consistent with our in vitro data; since
Hul5 does not seem to function efficiently unless the con-
jugate is already bound to the proteasome, Hul5 may be
inherently unable to promote the initial recognition of
a substrate by the proteasome. These properties of Hul5
would predict a facilitative rather than obligatory role in
degradation. If Hul5 is, as we propose, irrelevant to the ini-
tial recognition event, it could promote substrate turnover
by slowing dissociation of the substrate from the protea-
some, thus increasing the probability of degradation as
the outcome of a particular substrate-proteasome-bind-
ing event.
Opposing Activities of Hul5 and Ubp6
Our data suggest that the chain-elongating activity of Hul5
functions specifically in opposition to deubiquitination by
Ubp6. That is, Hul5 serves not simply to elongate chains
but to preserve chains against attrition by Ubp6. Although
opposing pairs of ligases and deubiquitinating enzymes
are probably rare, several have been described (Wertz
et al., 2004; Rumpf and Jentsch, 2006; Kee et al., 2005;
and references therein). Hul5 and Ubp6 appear to provide
the first example of an E4 and a deubiquitinating enzyme
that reside simultaneously on the same protein complex.
We recently found that Ubp6 can, for at least some sub-
strates, act noncatalytically to inhibit the proteasome
(Hanna et al., 2006). The degradation delay resulting
from this activity of Ubp6 may be significant for the func-
tion of Hul5 because it provides a window of time neces-
sary for refashioning of ubiquitin chains by Hul5 and Ubp6.
When Ubp6 inhibits the proteasome, it also prevents chain
removal by Rpn11, directly or indirectly. Thus, Ubp6 op-
poses Rpn11 via its noncatalytic activity and Hul5 via its
catalytic activity.1410 Cell 127, 1401–1413, December 29, 2006 ª2006 Elsevier IThe chain-extending activity of Hul5 may promote deg-
radation of a protein by producing a longer chain that
binds the proteasome more tightly. The greater effective-
ness of long chains in targeting degradation (Thrower
et al., 2000) may reflect their ability to engage multiple
proteasomal ubiquitin receptors. A second possible view
is that Hul50s chain-extending activity rarely affects net
chain growth but serves to prevent Ubp6 from shortening
the chain to such an extent that it can no longer tether the
substrate to the proteasome. In either scenario, the com-
bined effect of Hul5 and Ubp6 in regulating the lengths of
chains on proteasome-bound conjugates may function
principally to modulate the dissociation rate of substrate
from the proteasome (Varshavsky, 1996) and, as a conse-
quence, the probability of the substrate’s degradation.
ATP-dependent proteases from eukaryotes and pro-
karyotes share many properties but differ in that only eu-
karyotic systems show ubiquitin dependence. An impor-
tant aspect of this difference that, to our knowledge,
has not been commented upon is that the reversibility of
the ubiquitin targeting signal allows eukaryotic protea-
somes in particular to play an active role in modulating
the strength of the targeting signal. Our studies suggest
that Hul5 and Ubp6 are key factors that provide this
capacity.
A Scaffold on the ProteasomeMay Organize Factors
that Act on Ubiquitin Chains
Many of the proteins that mediate the dynamics of ubiqui-
tin chains on the proteasome are not true proteasome
subunits but are weakly associated factors. This applies
to Hul5, Ubp6, and Ubl-Uba proteins, such as Rad23,
that are major mediators of ubiquitin conjugate delivery
to the proteasome. Thus, chain delivery, elongation, and
attrition are all mediated at least in part through pro-
teasome-associated proteins. Interestingly, proteasome
subunits Rpn1 and Rpn2 appear to serve together as
a scaffold that organizes these factors. Rpn1 is a receptor
for both Rad23 and Ubp6 (Elsasser et al., 2002; Leggett
et al., 2002; Saeki et al., 2002; Seeger et al., 2003; Elsasser
et al., 2004; Stone et al., 2004), whereas Rpn2 binds Hul5
avidly (Figure 7). In addition, both Rpn1 and Rpn2 cross-
link to Rad23 (Saeki et al., 2002), suggesting that Rpn1
and Rpn2 are close neighbors. Rpn1 and Rpn2 are both
components of the base, have similar structural motifs
and size (Kajava, 2002), may bind one another (Gorbea
et al., 2000), and are thought to have evolved from a com-
mon ancestor. Thus we propose that Rpn1 and Rpn2 im-
pose a close alignment of Rad23, Ubp6, and Hul5 on the
proteasome. The stabilization of Hul5 binding to the pro-
teasome by Ubp6 supports this view. The detailed organi-
zation of these factors may be significant since both Hul5
and Ubp6 appear to work efficiently only in the context of
the proteasome (Leggett et al., 2002; Hanna et al., 2006;
this work). This may be due in part to the proteasome play-
ing a role in the presentation of ubiquitin chains to these
enzymes.nc.
Convergence of Cdc48 and the Proteasome
Cdc48, also known as p97 and VCP, is a homohexameric
ATPase ring complex. It falls into the AAA family of AT-
Pases, which also includes the Rpt subunits of the protea-
some. Interestingly, many AAA proteins exhibit protein-
unfolding activity. Recent studies have revealed that
Cdc48 is an intricate assembly for the processing of ubiq-
uitin-protein conjugates (Richly et al., 2005; Rumpf and
Jentsch, 2006; reviewed in Elsasser and Finley, 2005).
Some proteins that are ubiquitinated and destined for
degradation are shuttled first to Cdc48, where their ubiq-
uitin chains are extended to a length required for asso-
ciation with the proteasome (Richly et al., 2005). These
remarkable activities of Cdc48 are not intrinsic to its
ATPase rings but reflect the properties of associated co-
factors: ubiquitin receptors such as Ubx-Uba proteins,
an E4 enzyme known as Ufd2, and the Otu1 deubiquitinat-
ing enzyme (Rumpf and Jentsch, 2006). Based in part on
the present results, it can be seen that the ensemble of
Cdc48 cofactors is deeply similar to that of the protea-
some. Thus, Ubx-Uba proteins are cognates of Ubl-Uba
proteins, Otu1 is a cognate of Ubp6, and Ufd2 is a cognate
of Hul5. This represents a dramatic evolutionary conver-
gence, especially because for the most part, these factors
cannot have been produced by a recent evolutionary bi-
furcation. For example, while Hul5 is a HECT-domain
ubiquitin ligase, Ufd2 is a member of the U-box family of
ligases. Similarly, Ubp6 falls into the DUB family of ligases,
and Otu1 falls into the OTU family. Even Cdc48 apparently
diverged from its sister subunits in the proteasome far be-
fore the eukaryotic radiation and thus prior to the evolution
of ubiquitination.
Despite these similarities, key properties of these com-
plexes differ, and in particular Hul5 differs functionally
from Ufd2. For example, we have found that the binding
of Hul5 to proteasomes is promoted by Ubp6. In contrast,
the binding of Ufd2 and Otu1 to the same Cdc48 complex
is thought to be disfavored (Rumpf and Jentsch, 2006),
so that Ufd2 and Otu1 presumably act on distinct conju-
gates while positioned on different complexes. The Ufd2
reaction, as presently understood, stereotypically takes
substrates with chains of one or two ubiquitin groups
and extends them to approximately six groups (Richly
et al., 2005). The Hul5 reaction seems to embrace a
greater range of chain lengths and to be more dynamic,
in that it involves a competition with chain attrition by
Ubp6.
Although it is the final arbiter of protein degradation, the
proteasome has traditionally been viewed as having a pas-
sive role. It has been assumed that the fate of individual
substrates has effectively been determined before their
engagement by the proteasome, primarily through the ac-
tivity of E3 enzymes. The discovery that Hul5 and Ubp6
mediate powerful ubiquitin-chain-remodeling activities
on the proteasome suggests that this view may be too
simplistic. In a multistep pathway such as the ubiquitin-
proteasome system, the capacity to control the final and
only irreversible step in protein breakdown should be ad-Cell 1vantageous. Our data suggest a new discriminatory step
in protein breakdown, in which substrates are actively
scrutinized by the proteasome.
EXPERIMENTAL PROCEDURES
Yeast Strains and Media
Media are described in the Supplemental Data. Strain genotypes are
given in Table S1.
Purification of Hul5, Proteasomes, and Proteasome
Subcomplexes
Hul5 was purified using Hul5-TEV-ProA (SBC8) following the proce-
dure described for proteasome purification (Leggett et al., 2002), ex-
cept that binding and washing buffers were 50 mM Tris-HCl (pH 7.5),
1 mM EDTA, and 300 mM NaCl. Procedures for proteasome purifica-
tion are given in the Supplemental Data.
Assays of Ubiquitin-Protein Ligase Activity
Incubations were performed in 25 mM Tris-HCl (pH 7.5), 1 mM DTT,
0.5 mM EDTA, 5 mM MgCl2, and 5 mM ATP buffer in 100 ml reactions
at 30C supplied with 2 mg of holoenzyme, 0.1 mg of E1, and 1 mg of ei-
ther biotinylated, 6-histidine-tagged ubiquitin or mutated ubiquitins.
Assays with WT ubiquitin contained 21 mg of this molecule per reac-
tion. Depending on the reaction, additional reagents included 0.1 mg
Hul5, 0.1 mg E2 (Ubc4 or UbcH5), 10 mM PS341, 10 mM o-phenanthro-
line, 0.1 mg tetraubiquitin, 0.5 mg ubiquitin chains, or 1 mg ubiquitin-
aldehyde. When required, ATP was depleted by adding hexokinase
(0.3 units/ml) and glucose (10 mM) for 15 min at 30C. A description
of preincubations of holoenzyme and conjugate substrates is in the
Supplemental Data.
Protein Turnover Analysis
Cells were grown in YPD media. Logarithmically growing cells were
treated with 100 mg/ml cycloheximide, and time points were taken.
Samples were analyzed by immunoblot, using HRP-conjugated sec-
ondary antibodies and ECL detection or 125I-protein A followed by
quantitation with a PhosphorImager.
Mass Spectrometry
Gel slices were incubated with trypsin. Digest products were mixed
with isotope-labeled internal standard peptides for both K48- and
K63-linked polyubiquitin chains. A fraction of the sample correspond-
ing to 0.2 pmol of each internal standard peptide was analyzed by
LC-MS/MS using an LTQ-FT mass spectrometer. The MS spectra
shown were obtained as an average across the eluted peak.
Supplemental Data
Supplemental Data include three figures, two tables, Experimental
Procedures, and References and can be found with this article online
at http://www.cell.com/cgi/content/full/127/7/1401/DC1/.
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